about
Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressorFeedback circuit among INK4 tumor suppressors constrains human glioblastoma developmentHigh-resolution genomic profiles of human lung cancerPassenger deletions generate therapeutic vulnerabilities in cancerPLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomasA brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticleMET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinibIntegrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivoAn inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.The tyrosine phosphatase PTPRD is a tumor suppressor that is frequently inactivated and mutated in glioblastoma and other human cancersGenomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutationsThe somatic genomic landscape of glioblastomaLoss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesisMalignant astrocytic glioma: genetics, biology, and paths to treatmentmicroRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma.Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations.Molecular characterization of the tumor microenvironment in breast cancer.Integrative genome comparison of primary and metastatic melanomas.Advanced imaging in brain tumor surgery.p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies.The phosphatase and tensin homolog regulates epidermal growth factor receptor (EGFR) inhibitor response by targeting EGFR for degradationNeurosurgery for brain tumors: update on recent technical advances.Mig-6 controls EGFR trafficking and suppresses gliomagenesisRecruited cells can become transformed and overtake PDGF-induced murine gliomas in vivo during tumor progressionProteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.Transcriptional diversity of long-term glioblastoma survivors.Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma.Protein phosphatase 2A mediates dormancy of glioblastoma multiforme-derived tumor stem-like cells during hypoxia.Glioblastoma stem-like cells give rise to tumour endothelium.PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas.Identification of DOK genes as lung tumor suppressors.Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis.Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMOMolecular diversity of astrocytes with implications for neurological disorders.Sleeping Beauty mouse models identify candidate genes involved in gliomagenesis.Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.High-resolution characterization of the pancreatic adenocarcinoma genome.
P50
Q24299628-3D19AE64-158D-4AB1-A06D-9FF9482DE08CQ24317761-C25CD0E7-9B5D-4F92-8355-5A3ECECD61E2Q24530598-AA839E63-2BF6-41C0-9464-7D9BBDD177D5Q24598469-56FD4335-A0A7-491F-8642-D0FA829D2A89Q24615768-3D1C5859-BE57-4CB6-9696-7C10644DE6F1Q24615790-8825C2A2-A3EE-4E35-A062-4A6DAE036CA8Q24646295-401ED49A-A3B6-415C-A6C1-C071BF0CE919Q24651548-A5AFAF5F-5E6C-4E01-99B3-81B78EE0EBA9Q24657924-A00A21B7-1852-4DE9-BB11-2002823AE844Q27852141-502E5CD1-E5B4-4250-A547-CC691620F5D0Q27853175-FEFFC08F-F44E-4202-A9F6-3883800B6312Q28115840-8C4A8236-AE76-4225-B204-27B0350C827BQ28237528-06C71B6C-BF5F-4CEC-9AA1-25FB5A5B0FFFQ28300185-A78D1A96-0E7A-494F-A695-CC169F670AF4Q28584911-474B1D95-00ED-460E-B4A5-30539C8AF80CQ29618156-448D5B90-087C-4729-AD36-9143E1E7218CQ30570563-6625DD7F-0A2A-46C4-A848-236D4C31E437Q30885944-DAB37150-4072-4D99-8392-64A162CF5782Q31095898-5BA3EFD0-2711-440F-8360-CAAC0A159D0AQ33592837-BF977461-9729-4F2E-A778-E3A8F9B31FC2Q33657690-7DF2258E-E13E-4B6C-952D-A39C81E14AE9Q33733341-47B19382-555E-4DCF-83B8-5AF1672B7E38Q33744534-809B2572-0034-407E-89F2-DF0A54860B17Q33778905-863EF542-E624-4E71-B1FC-C4375F560C4CQ33822509-C014BEE8-3E9F-4B10-8DF7-037FA42BD2B9Q33859568-B0CE8005-457A-4E17-B0BF-3CAFDC5D8852Q33960280-61F4AA1E-A3F9-42AF-8F34-CDD68D195ADEQ33962607-0FC457CD-DFCE-4423-9248-203A9F768AFEQ34062027-41E85332-F5B5-48FA-A611-726459E3C62EQ34069375-D1E9B97D-7C75-49BE-8931-97E34EB6491DQ34130984-B8630DCD-B7B0-43D7-AE52-D592FD0DF120Q34151507-57A56D02-675A-41B3-9BF5-D39724888AF6Q34164924-B50FB6DF-D8D7-4C53-9599-2B375DECE95FQ34207099-98682115-F68B-4FE4-960C-39666346B6E9Q34301317-19A440AF-5CB4-476C-A177-859B79479D07Q34324259-156B2575-C72D-4BE4-B68C-F4EBA0DEF2BAQ34375615-BFF68F38-9468-4C22-AAD1-E857DFF56C2BQ34571956-663CC2D5-3EAE-4B0C-A70B-913957D65FFCQ34596182-B3AAC0EA-B5A8-4C04-AB65-7573392C4AC7Q34834994-DD5A9265-51E9-4550-9C67-DE5EEA357DFF
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Cameron Brennan
@ast
Cameron Brennan
@en
Cameron Brennan
@es
Cameron Brennan
@fr
Cameron Brennan
@nl
Cameron Brennan
@sl
type
label
Cameron Brennan
@ast
Cameron Brennan
@en
Cameron Brennan
@es
Cameron Brennan
@fr
Cameron Brennan
@nl
Cameron Brennan
@sl
prefLabel
Cameron Brennan
@ast
Cameron Brennan
@en
Cameron Brennan
@es
Cameron Brennan
@fr
Cameron Brennan
@nl
Cameron Brennan
@sl
P106
P1153
7102931407
P21
P31
P496
0000-0003-4064-8891